Core Laboratories IncCLB
Price$9.76Intrinsic value$15.1956% above price

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
8.8%projected annual EPS growth
As of 27 Aug 2026
Analyst Coverage
3analysts covering
Consensus: NeutralAs of 18 Aug 2026
FY EPS (est.)
$0.43next fiscal year
As of 18 Aug 2026
Reporting Calendar
EventExpected Date
Q3 2026 Earnings Release21 Oct 2026
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly121.8MTarget: 123,000,000 to 131,000,000
Operating Income (Ex-Items) Quarterly6.6MTarget: 6,400,000 to 10,200,000
Diluted EPS (Ex-Items) Quarterly0.1Target: 0.06 to 0.12
Free Cash Flow Quarterly500KTarget: Positive generation
Watch Items
  • Middle East Geopolitical ConflictTrigger: Prolonged shipping delays of energetic products or disruption to regional laboratory operationsAction: Re-evaluate international revenue projections and adjust logistics channels for the Production Enhancement segment.
  • North American Land Completion ActivityTrigger: Rig count declines or severe weather disruptions reducing completion product manufacturing utilizationAction: Assess cost-containment measures and adjust manufacturing capacity in the Production Enhancement segment.
Sign in / Sign up to read more

Research as of 19 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.